CDW(CDW)
CDW
Q4 2026 EPS Estimate
$2.91
Nov 3, 2026 · Reports before open
Revenue Estimate
$6.17B
FY2026E EPS$10.85
FY2027E EPS$11.84
Analyst Sentiment
Wall St. Consensus
Buy18 analysts·Moderate coverage
69
Score
13 Buy (72%)5 Hold (28%)0 Sell (0%)
Rating Breakdown
Strong Buy
16%
Buy
1267%
Hold
528%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$123.00
-11.8%
Consensus
$147.00
+5.4%
Bull
$171.00
+22.7%
12-Month Target Range18 analysts
$123.00$147.00$171.00
Current $139.42Consensus
Current Price
$139.42
Upside to Consensus
$7.58
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+3.56%
EPS+9.10%
FY2028
Rev+3.31%
EPS+9.28%
FY2029
Rev+5.29%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $24.02B | $24.88B | $25.70B | $27.06B |
| Low | $23.42B | $23.95B | $25.20B | $26.36B |
| High | $24.50B | $25.54B | $26.32B | $27.73B |
| EBITDA Avg | $2.37B | $2.45B | $2.53B | $2.67B |
| Low | $2.31B | $2.36B | $2.48B | $2.60B |
| High | $2.41B | $2.52B | $2.59B | $2.73B |
| EBIT Avg | $1.95B | $2.01B | $2.08B | $2.19B |
| Low | $1.90B | $1.94B | $2.04B | $2.13B |
| High | $1.98B | $2.07B | $2.13B | $2.25B |
| Net Income Avg | $1.39B | $1.60B | $1.71B | — |
| Low | $1.39B | $1.48B | $1.67B | — |
| High | $1.49B | $1.71B | $1.74B | — |
| EPS Avg | $10.85 | $11.84 | $12.93 | — |
| Low | $10.52 | $11.24 | $12.67 | — |
| High | $11.29 | $12.96 | $13.20 | — |
| Analysts (Rev / EPS) | 6 / 6 | 7 / 7 | 5 / 2 | 2 / — |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $6.07B | $5.80B | $5.80B | $6.62B | $6.40B | $6.06B | $5.84B | $6.84B |
| Low | $5.92B | $5.50B | $5.60B | $6.40B | $6.19B | $5.86B | $5.64B | $6.61B |
| High | $6.21B | $5.95B | $5.94B | $6.79B | $6.56B | $6.22B | $5.99B | $7.01B |
| EBITDA Avg | $598M | $571M | $571M | $653M | $631M | $598M | $576M | $674M |
| Low | $583M | $542M | $552M | $631M | $610M | $578M | $556M | $651M |
| High | $612M | $586M | $586M | $669M | $647M | $613M | $590M | $691M |
| EBIT Avg | $491M | $469M | $469M | $536M | $518M | $491M | $473M | $554M |
| Low | $479M | $445M | $454M | $518M | $501M | $475M | $457M | $535M |
| High | $503M | $482M | $481M | $550M | $531M | $503M | $485M | $567M |
| Net Income Avg | $372M | $357M | $317M | $386M | $415M | $395M | $318M | $397M |
| Low | $355M | $338M | $304M | $369M | $397M | $378M | $305M | $379M |
| High | $401M | $382M | $328M | $398M | $429M | $408M | $329M | $409M |
| EPS Avg | $2.92 | $2.80 | $2.49 | $3.03 | $3.26 | $3.10 | $2.50 | $3.11 |
| Low | $2.79 | $2.65 | $2.38 | $2.90 | $3.12 | $2.97 | $2.39 | $2.98 |
| High | $3.15 | $3.00 | $2.57 | $3.13 | $3.36 | $3.20 | $2.58 | $3.21 |
| Analysts (Rev / EPS) | 6 / 7 | 6 / 7 | 3 / 2 | 3 / 2 | 3 / 2 | 3 / 5 | 4 / 6 | 4 / 5 |